Skip to main content

and
  1. No Access

    Article

    Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene

    The heterogeneity of acute myeloid leukemia is reflected in many clinical, biological and genetic features that are used to predict the response to therapy. On the basis of chromosome aberrations patients can ...

    WJC Rombouts, B Löwenberg, WLJ van Putten, RE Ploemacher in Leukemia (2001)

  2. No Access

    Article

    A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group

    The purpose of this study was to determine the safety and efficacy of filgrastim as an adjunct to induction and consolidation chemotherapy in poor risk patients with myelodysplastic syndrome (MDS). Filgrastim ...

    GJ Ossenkoppele, B van der Holt, GEG Verhoef, SMGJ Daenen, LF Verdonck in Leukemia (1999)

  3. No Access

    Article

    Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

    The clinical use of autologous marrow transplantation in acute myeloid leukemia (AML) has been hampered by the inability to collect adequate numbers of cells after remission induction chemotherapy and the nota...

    E Vellenga, WLJ van Putten, MA Boogaerts, SMGJ Daenen in Bone Marrow Transplantation (1999)

  4. No Access

    Article

    Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up

    Suppression of the secretion of prolactin, growth hormone and insulin-like growth factor 1 (IGF-1) might be important in the growth regulation and treatment of breast cancer. Because oestrogens may counteract ...

    M Bontenbal, JA Foekens, SWJ Lamberts, FH de Jong in British Journal of Cancer (1998)

  5. No Access

    Article

    Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

    Docetaxel, a new semisynthetic taxoid that has demonstrated promising activity as an antineoplastic agent, was administered in combination with cisplatin to 63 patients in a dose-escalating study. As both drug...

    PHE Hilkens, LC Pronk, J Verweij, CJ Vecht, WLJ van Putten in British Journal of Cancer (1997)

  6. No Access

    Article

    Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer

    PS2, an oestrogen-inducible protein, was measured in the cytosol of 230 primary tumours from patients who were subjected to first-line tamoxifen therapy for advanced disease without prior adjuvant therapy with...

    JA Foekens, H Portengen, MP Look, WLJ van Putten, B Thirion in British Journal of Cancer (1994)

  7. No Access

    Article

    Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients

    Tyrosine-specific protein kinase (TPK) has been associated with the cytoplasmic domain of growth factor receptors as well as oncoproteins. Enzymatic activation appears to be a major initial event in these sign...

    S Romain, O Chinot, JGM Klijn, WLJ van Putten, O Guirou in British Journal of Cancer (1994)

  8. No Access

    Article

    Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases

    Of 139 node-positive breast cancer patients treated with adjuvant chemotherapy, the pre-treatment levels of glutathione S-transferase (GST) classes alpha, mu and pi, were determined by immuno-quantification on...

    WHM Peters, HMJ Roelofs, WLJ van Putten, JBMJ Jansen in British Journal of Cancer (1993)

  9. No Access

    Article

    Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer

    In a group of seventy patients with small cell lung cancer the prognostic value of serum tumour markers was determined. Thymidine kinase (TK), tissue polypeptide antigen (TPA) and lactate dehydrogenase (LDH) b...

    A van der Gaast, WLJ van Putten, R Oosterom, M Cozijnsen in British Journal of Cancer (1991)